CD34+selected autologous peripheral blood stem cell transplantation in neuroblastoma

被引：0
|
作者：
Ahn, HS
Kang, HJ
Choi, HS
Shin, HY
机构：
[1] Seoul Natl Univ, Seoul 151, South Korea
[2] Natl Canc Ctr, Goyangsi, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [31] Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in a child with neuroblastoma relapse after autologous peripheral blood stem cell transplantation
    Weng, Te-Fu
    Wu, Kang-Hsi
    PEDIATRIC BLOOD & CANCER, 2022, 69 (02)
  • [32] Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells
    Baron, F
    Baudoux, E
    Frère, P
    Tourqui, S
    Schaaf-Lafontaine, N
    Greimers, R
    Herens, C
    Fillet, G
    Beguin, Y
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (02): : 301 - 314
  • [33] CD34+Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation
    Stasia, Alessandra
    Ghiso, Anna
    Raiola, Anna Maria
    Galaverna, Federica
    Varaldo, Riccardo
    Gualandi, Francesca
    Dominietto, Alida
    Pozzi, Sarah
    Luchetti, Silvia
    Pogliani, Enrico Maria
    Bacigalupo, Andrea
    BLOOD, 2013, 122 (21)
  • [34] Autologous peripheral blood selected CD34+ cell transplantation for the treatment of severe progressive systemic sclerosis
    Locatelli, F
    Ravelli, A
    Maccario, R
    Montagna, D
    Perotti, C
    DeBenedetti, F
    Zecca, M
    Bonetti, F
    Giorgiani, G
    DeStefano, P
    Martini, A
    BLOOD, 1996, 88 (10) : 3865 - 3865
  • [35] CD34+Selected Cells "Boost" for Poor Graft Function Post Allogeneic Stem Cell Transplantation
    Mohty, Razan
    Ruggeri, Annalisa
    Battipaglia, Giorgia
    Malard, Florent
    Brissot, Eolia
    Belhocine, Ramdane
    Eder, Sandra
    Giannotti, Federica
    Dulery, Remy
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [36] CNS recurrence following CD34+ peripheral blood stem cell transplantation in stage 4 neuroblastoma
    Choi, HS
    Koh, SH
    Park, ES
    Shin, HY
    Ahn, HS
    PEDIATRIC BLOOD & CANCER, 2005, 45 (01) : 68 - 71
  • [37] CD34+selected stem cell boost for CMV induced poor graft function after allogeneic stem cell transplantation
    Abdullayev, E.
    Abdullayev, E.
    Baurmann, H.
    Fuhrmann, S.
    Glass, B.
    LEUKEMIA RESEARCH, 2019, 85 : S45 - S45
  • [38] Autologous blood stem cell transplantation with CeprateR selected CD34+ cells for multiple myeloma.
    Volin, L
    Juvonen, E
    Elonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [39] Peripheral blood CD34+ cell count as a predictor of adequacy of hematopoietic stem cell collection for autologous transplantation
    Combariza, Juan F.
    Barco, Gloria
    Estrada, Angela
    Jaramillo, Sergio
    Arango, Marcos
    IATREIA, 2016, 29 (04) : 424 - 432
  • [40] Optimal CD34+ cell dose in autologous peripheral-blood stem-cell transplantation -: In reply
    Siena, S
    Schiavo, R
    Sartore-Bianchi, A
    Pedrazzoli, P
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3319 - 3320
12345